Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Guanylate cyclase-activating protein 2 (GCAP2; GUCA1B) has been implicated in autosomal dominant retinitis pigmentosa (RP) following targeted screening in Japanese RP cohorts. In 63 ADRP and 33 ARRP unrelated patients, a novel heterozygous transitional mutation c.469G>A (p.Gly157Arg) was identified in three independent families (three probands) demonstrating variable expressivity between RP and macular involvement (PMID:15452722).
Wild-type GCAP2 regulates phototransduction via high-affinity Ca2+ binding and modulates photoreceptor guanylyl cyclase (RetGC) activity independent of N-terminal myristoylation, establishing a baseline for comparison with disease variants (PMID:9162068).
Segregation analysis across the three families showed the c.469G>A (p.Gly157Arg) variant in six clinically affected members (five with RP, one with macular degeneration) and one asymptomatic carrier, consistent with incomplete penetrance (PMID:15452722).
Cellular studies demonstrate that the bovine-equivalent G157R substitution enhances GCAP2 phosphorylation and causes retention at the inner segment in rod photoreceptors, implicating disrupted trafficking in pathogenesis (PMID:29440717).
Biochemical characterization of the human GCAP2 G157R variant revealed a molten globule-like conformation, reduced cation-binding affinity and a propensity to aggregate, likely driving dominant-negative or toxic gain-of-function effects (PMID:33812995).
Together, the genetic findings and concordant functional data support a pathogenic role of GUCA1B c.469G>A (p.Gly157Arg) in autosomal dominant RP with variable expressivity and incomplete penetrance. Key take-home: GUCA1B c.469G>A (p.Gly157Arg) is a clinically actionable variant for genetic diagnosis and counseling in RP.
Gene–Disease AssociationModerate3 unrelated probands, segregation in six family members across three families, concordant functional data Genetic EvidenceModerateThree ADRP probands with c.469G>A (p.Gly157Arg) and segregation in six relatives; variable expressivity and incomplete penetrance Functional EvidenceModerateBiochemical and cellular assays demonstrate misfolding, cation-binding defects, aggregation and trafficking abnormalities consistent with disease mechanism |